| Primary |
| Hepatitis C |
69.4% |
| Product Used For Unknown Indication |
13.8% |
| Chronic Hepatitis C |
10.1% |
| Hypertension |
1.2% |
| Depression |
0.7% |
| Hepatic Cirrhosis |
0.7% |
| Anaemia |
0.6% |
| Hepatitis |
0.6% |
| Hepatitis C Virus Test Positive |
0.4% |
| Pain |
0.4% |
| Diabetes Mellitus |
0.3% |
| Anxiety |
0.3% |
| Hiv Infection |
0.3% |
| Chronic Hepatitis |
0.2% |
| Prophylaxis |
0.2% |
| Neutropenia |
0.2% |
| Insomnia |
0.2% |
| Hypothyroidism |
0.2% |
| Vitamin Supplementation |
0.2% |
| Gastrooesophageal Reflux Disease |
0.2% |
|
| White Blood Cell Count Decreased |
16.1% |
| Vomiting |
9.7% |
| Weight Decreased |
9.5% |
| Fatigue |
8.5% |
| Rash |
7.9% |
| Anaemia |
7.5% |
| Nausea |
6.9% |
| Dysgeusia |
3.9% |
| Drug Ineffective |
3.3% |
| Pruritus |
3.1% |
| Red Blood Cell Count Decreased |
2.9% |
| Pyrexia |
2.7% |
| Haemoglobin Decreased |
2.6% |
| Thrombocytopenia |
2.5% |
| Platelet Count Decreased |
2.4% |
| Influenza Like Illness |
2.4% |
| Neutropenia |
2.1% |
| Pneumonia |
2.1% |
| Pain |
2.0% |
| Headache |
1.9% |
|
| Secondary |
| Hepatitis C |
81.3% |
| Chronic Hepatitis C |
7.6% |
| Product Used For Unknown Indication |
6.1% |
| Hepatic Cirrhosis |
1.3% |
| Hypertension |
0.6% |
| Depression |
0.6% |
| Hepatitis |
0.4% |
| Anaemia |
0.3% |
| Diabetes Mellitus |
0.3% |
| Hiv Infection |
0.3% |
| Bronchitis |
0.2% |
| Liver Disorder |
0.2% |
| Hepatitis Infectious |
0.1% |
| Hepatitis B |
0.1% |
| Hepatitis C Virus Test Positive |
0.1% |
| Pain |
0.1% |
| Anxiety |
0.1% |
| Chronic Hepatitis |
0.1% |
| Hypothyroidism |
0.1% |
| Insomnia |
0.1% |
|
| White Blood Cell Count Decreased |
19.7% |
| Weight Decreased |
18.3% |
| Vomiting |
12.1% |
| Rash |
6.2% |
| Nausea |
5.2% |
| Anaemia |
4.7% |
| Fatigue |
3.8% |
| Pyrexia |
3.4% |
| Red Blood Cell Count Decreased |
3.0% |
| Weight Increased |
2.9% |
| Drug Ineffective |
2.5% |
| Platelet Count Decreased |
2.5% |
| Pruritus |
2.4% |
| Thrombocytopenia |
2.2% |
| Headache |
2.0% |
| Malaise |
2.0% |
| Somnolence |
2.0% |
| Neutropenia |
1.8% |
| Pain |
1.8% |
| Therapeutic Response Decreased |
1.6% |
|
| Concomitant |
| Hepatitis C |
64.7% |
| Product Used For Unknown Indication |
13.8% |
| Chronic Hepatitis C |
4.6% |
| Hypertension |
3.2% |
| Anaemia |
1.8% |
| Drug Dependence |
1.8% |
| Neutropenia |
1.8% |
| Gout |
0.9% |
| Hepatitis C Virus Test |
0.9% |
| Oestrogen Deficiency |
0.9% |
| Pain |
0.9% |
| Psoriasis |
0.9% |
| Hepatitis C |
0.5% |
| Attention Deficit/hyperactivity Disorder |
0.5% |
| Coma Hepatic |
0.5% |
| Gastrooesophageal Reflux Disease |
0.5% |
| Haemoglobin Decreased |
0.5% |
| Hepatitis |
0.5% |
| Pruritus |
0.5% |
| Psoriatic Arthropathy |
0.5% |
|
| White Blood Cell Count Decreased |
9.3% |
| Hypotension |
7.4% |
| Nausea |
7.4% |
| Tremor |
7.4% |
| Vomiting |
7.4% |
| Anaemia |
5.6% |
| Pain |
5.6% |
| Platelet Count Decreased |
5.6% |
| Rash |
5.6% |
| Urinary Tract Infection |
5.6% |
| Weight Decreased |
5.6% |
| Death |
3.7% |
| Leukopenia |
3.7% |
| Productive Cough |
3.7% |
| Spinal Fracture |
3.7% |
| Thrombocytopenia |
3.7% |
| White Blood Cell Disorder |
3.7% |
| Accidental Exposure To Product |
1.9% |
| Angioedema |
1.9% |
| Chest Pain |
1.9% |
|
| Interacting |
| Hepatitis C |
53.1% |
| Hepatitis Viral |
18.8% |
| Depression |
9.4% |
| Organ Transplant |
6.3% |
| Type 1 Diabetes Mellitus |
6.3% |
| Hypothyroidism |
3.1% |
| Prophylaxis |
3.1% |
|
| Renal Impairment |
22.2% |
| Withdrawal Syndrome |
22.2% |
| Neutropenia |
11.1% |
| Pneumonia |
11.1% |
| Toxic Skin Eruption |
11.1% |
| Weight Decreased |
11.1% |
| White Blood Cell Count Decreased |
11.1% |
|
